Archer TC, Mahoney EL, Pomeroy SL. Medulloblastoma: molecular classification-based personal therapeutics. Neurotherapeutics. 2017;14:265–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aktekin EH, Kutuk MO, Sangun O, Yazici N, Caylakli F, Erol I, et al. Late effects of medulloblastoma treatment: multidisciplinary approach of survivors. Childs Nerv Syst. 2024;40:417–25.

Article  PubMed  Google Scholar 

Cho YJ, Tsherniak A, Tamayo P, Santagata S, Ligon A, Greulich H, et al. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J Clin Oncol. 2011;29:1424–30.

Article  PubMed  Google Scholar 

Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17:832–45.

Article  CAS  PubMed  Google Scholar 

Van Ommeren R, Garzia L, Holgado BL, Ramaswamy V, Taylor MD. The molecular biology of medulloblastoma metastasis. Brain Pathol. 2020;30:691–702.

Article  PubMed  PubMed Central  Google Scholar 

Spix C, Erdmann F, Grabow D, Ronckers C. Childhood and adolescent cancer in Germany-an overview. J Health Monit. 2023;8:79–93.

PubMed  PubMed Central  Google Scholar 

Korshunov A, Sahm F, Stichel D, Schrimpf D, Ryzhova M, Zheludkova O, et al. Molecular characterization of medulloblastomas with extensive nodularity (MBEN). Acta Neuropathol. 2018;136:303–13.

Article  CAS  PubMed  Google Scholar 

Garcia-Lopez J, Kumar R, Smith KS, Northcott PA. Deconstructing sonic hedgehog medulloblastoma: molecular subtypes, drivers, and beyond. Trends Genet. 2021;37:235–50.

Article  CAS  PubMed  Google Scholar 

Choi JY. Medulloblastoma: current perspectives and recent advances. Brain Tumor Res Treat. 2023;11:28–38.

Article  PubMed  PubMed Central  Google Scholar 

Hammoud H, Saker Z, Harati H, Fares Y, Bahmad HF, Nabha S. Drug repurposing in medulloblastoma: challenges and recommendations. Curr Treat Options Oncol. 2020;22:6.

Article  PubMed  Google Scholar 

Hovestadt V, Ayrault O, Swartling FJ, Robinson GW, Pfister SM, Northcott PA. Medulloblastomics revisited: biological and clinical insights from thousands of patients. Nat Rev Cancer. 2020;20:42–56.

Article  CAS  PubMed  Google Scholar 

Leary SE, Olson JM. The molecular classification of medulloblastoma: driving the next generation clinical trials. Curr Opin Pediatr. 2012;24:33–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin AM, Raabe E, Eberhart C, Cohen KJ. Management of pediatric and adult patients with medulloblastoma. Curr Treat Options Oncol. 2014;15:581–94.

Article  PubMed  PubMed Central  Google Scholar 

Rechberger JS, Toll SA, Vanbilloen WJF, Daniels DJ, Khatua S. Exploring the molecular complexity of medulloblastoma: implications for diagnosis and treatment. Diagnostics. 2023;13:2398.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosenberg T, Cooney T. Current open trials and molecular update for pediatric embryonal tumors. Pediatr Neurosurg. 2023;58:299–306.

Article  PubMed  Google Scholar 

Mynarek M, von Hoff K, Pietsch T, Ottensmeier H, Warmuth-Metz M, Bison B, et al. Nonmetastatic medulloblastoma of early childhood: results from the prospective clinical trial HIT-2000 and an extended validation cohort. J Clin Oncol. 2020;38:2028–40.

Article  CAS  PubMed  Google Scholar 

Rutkowski S, von Hoff K, Emser A, Zwiener I, Pietsch T, Figarella-Branger D, et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol. 2010;28:4961–8.

Article  PubMed  Google Scholar 

von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, et al. Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol. 2011;13:669–79.

Article  Google Scholar 

Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, et al. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial. Lancet Oncol. 2018;19:768–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guerrini-Rousseau L, Abbas R, Huybrechts S, Kieffer-Renaux V, Puget S, Andreiuolo F, et al. Role of neoadjuvant chemotherapy in metastatic medulloblastoma: a comparative study in 92 children. Neuro Oncol. 2020;22:1686–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cooney T, Lindsay H, Leary S, Wechsler-Reya R. Current studies and future directions for medulloblastoma: A review from the Pacific Pediatric Neuro-oncology Consortium (PNOC) disease working group. Neoplasia. 2023;35:100861.

Article  PubMed  Google Scholar 

Bagchi A, Dhanda SK, Dunphy P, Sioson E, Robinson GW. Molecular classification improves therapeutic options for infants and young children with medulloblastoma. J Natl Compr Cancer Netw. 2023;21:1097–105.

Article  Google Scholar 

Fang FY, Rosenblum JS, Ho WS, Heiss JD. New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma. Cancers. 2022;14:2285.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gajjar A, Robinson GW, Smith KS, Lin T, Merchant TE, Chintagumpala M, et al. Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial (SJMB03). J Clin Oncol. 2021;39:822–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hanz SZ, Adeuyan O, Lieberman G, Hennika T. Clinical trials using molecular stratification of pediatric brain tumors. Transl Pediatr. 2020;9:144–56.

Article  PubMed  PubMed Central  Google Scholar 

Batora NV, Sturm D, Jones DT, Kool M, Pfister SM, Northcott PA. Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics. Neuroscience. 2014;264:171–85.

Article  CAS  PubMed  Google Scholar 

Kool M, Koster J, Bunt J, Hasselt NE, Lakeman A, van Sluis P, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One. 2008;3:e3088.

Article  PubMed  PubMed Central  Google Scholar 

Northcott PA, Buchhalter I, Morrissy AS, Hovestadt V, Weischenfeldt J, Ehrenberger T, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017;547:311–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Northcott PA, Shih DJ, Remke M, Cho YJ, Kool M, Hawkins C, et al. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol. 2012;123:615–26.

Article  CAS  PubMed  Google Scholar 

Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, et al. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012;123:465–72.

Article  CAS  PubMed  Google Scholar 

Archer TC, Ehrenberger T, Mundt F, Gold MP, Krug K, Mah CK, et al. Proteomics, post-translational modifications, and integrative analyses reveal molecular heterogeneity within Medulloblastoma subgroups. Cancer Cell. 2018;34:396–410.

Article  CAS  PubMed